Research Topics
| Rino RappuoliSummaryAffiliation: Novartis Institutes for BioMedical Research Publications
| Collaborators
|
Detail Information
Publications
Influenza: options to improve pandemic preparationRino Rappuoli
Novartis Vaccines and Diagnostics, Siena, Italy
Science 336:1531-3. 2012..Here, we review the options available in the short term and also briefly address the solutions that research may make available in the long term...
The design of semi-synthetic and synthetic glycoconjugate vaccinesPaolo Costantino
Novartis Vaccines, Via Fiorentina 1, Siena 53100, Italy
Expert Opin Drug Discov 6:1045-66. 2011..New and challenging targets for conjugate vaccines are represented by cancer and other non-infectious diseases...
ADITEC: joining forces for next-generation vaccinesRino Rappuoli
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Sci Transl Med 4:128cm4. 2012..The European Commission-sponsored Advanced Immunization Technologies project--ADITEC--brings together some of the leading laboratories in the field to tackle the problems that no lab can tackle in isolation...
Vaccines for the twenty-first century societyRino Rappuoli
Novartis Vaccines and Diagnostics Srl, Via Fiorentina 5, 53100 Siena, Italy
Nat Rev Immunol 11:865-72. 2011..Supported by the innovations derived from new technologies, vaccines will address the new needs of a twenty-first century society characterized by increased life expectancy, emerging infections and poverty in low-income countries...
Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related speciesClaudio Donati
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Genome Biol 11:R107. 2010..Streptococcus pneumoniae is one of the most important causes of microbial diseases in humans. The genomes of 44 diverse strains of S. pneumoniae were analyzed and compared with strains of non-pathogenic streptococci of the Mitis group...
Bridging the knowledge gaps in vaccine designRino Rappuoli
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Nat Biotechnol 25:1361-6. 2007
Building an insurance against modern pandemicsRino Rappuoli
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Curr Opin Investig Drugs 11:126-30. 2010..The lessons learned from the 2009 H1N1 pandemic are of paramount importance to develop more effective preparations against future pandemics...
A 2020 vision for vaccines against HIV, tuberculosis and malariaRino Rappuoli
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Nature 473:463-9. 2011..We also argue that new and innovative approaches to clinical trials will accelerate the availability of these vaccines...
Twenty-first century vaccinesRino Rappuoli
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Philos Trans R Soc Lond B Biol Sci 366:2756-8. 2011..However, for this to happen, we need to increase the public trust in vaccination so that vaccines can be perceived as the best insurance against most diseases across all ages...
Vaccine discovery and translation of new vaccine technologyRino Rappuoli
Novartis Vaccines, Siena, Italy
Lancet 378:360-8. 2011....
Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonizationLaura Serino
Research Centre, Novartis Vaccines, Via Fiorentina, 1, 53100 Siena, Italy
Mol Microbiol 64:1391-403. 2007..All together, these data suggest that the newly identified surface exposed protein Ng-OmpA represents a novel virulence factor of gonococcus...
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione
Chiron Srl, Via Fiorentina 1, 53100 Siena, Italy
Science 309:148-50. 2005..Multigenome analysis and screening described here represent a powerful strategy for identifying potential vaccine candidates against highly variable pathogens...
A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cellsFabio Bagnoli
Department of Cellular Microbiology and Bioinformatics, Novartis Vaccines, University of Siena, Siena 53100, Italy
J Bacteriol 190:5480-92. 2008..Thus, pneumococci encode at least two types of pili that play a role in the initial host cell contact to the respiratory tract and are potential antigens for inclusion in a new generation of pneumococcal vaccines...
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levelsGrazia Galli
Research Center, Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena 53100, Italy
Proc Natl Acad Sci U S A 106:3877-82. 2009..We suggest that CD4(+) T cell priming might be used as an early predictor of the immunogenicity of prepandemic vaccines...
Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier proteinKarin Baraldo
Research Center, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Infect Immun 73:5835-41. 2005..Taken together, these data show that the N19 polyepitope represents a strong and valid option for the generation of improved or new combined glycoconjugate vaccines...
Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidisMaria Scarselli
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
J Mol Biol 386:97-108. 2009....
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenEnrico Malito
Research Center, Novartis Vaccines and Diagnostics Srl, 53100 Siena, Italy
Proc Natl Acad Sci U S A 110:3304-9. 2013....
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery systemBarbara C Baudner
Research Center, Chiron Srl, Siena, Italy
J Infect Dis 189:828-32. 2004..These data could affect the design of efficacious mucosal vaccines and their safety...
The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signatureElaine Tritto
Novartis Vaccines and Diagnostics, Siena, Italy
J Immunol 179:5346-57. 2007..Our data suggest that LTK63 acts as an airway infection mimic that establishes a generic protective environment limiting respiratory infection by innate immune mechanisms and by improving adaptive responses to invading pathogens...
Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesinMaria Scarselli
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 61:631-44. 2006..Collectively, our results underline a putative role of NhhA in meningococcal pathogenesis and ascertain its structural and functional belonging to the emerging group of bacterial autotransporter adhesins with trimeric architecture...
Sortase A confers protection against Streptococcus pneumoniae in miceClaudia Gianfaldoni
Novartis Vaccines and Diagnostics Srl, Research Center, Siena, Italy
Infect Immun 77:2957-61. 2009..Taken together, our results suggest that SrtA is a good candidate for inclusion in a multicomponent, protein-based, pneumococcal vaccine...
Pilus operon evolution in Streptococcus pneumoniae is driven by positive selection and recombinationAlessandro Muzzi
Novartis Vaccines and Diagnostics, Siena, Italy
PLoS ONE 3:e3660. 2008....
Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg AMarkus Hilleringmann
Research Center, Novartis Vaccines and Diagnostics s r l, Siena, Italy
PLoS Pathog 4:e1000026. 2008..Combining the structural and functional data, a model emerges where the pilus RrgB backbone serves as a carrier for surface located adhesive clusters of RrgA that facilitates the interaction with the host...
Genome-based vaccine development: a short cut for the futureDanilo Gomes Moriel
Novartis Vaccines, Via Fiorentina 1, 53100, Siena, Italy
Adv Exp Med Biol 655:81-9. 2009..A lot of work must be done, but deciphering the information provided by genome sequences and using it to better understand the host-pathogen interactions has proved to be the key for protection...
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infectionKate L Seib
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 28:2416-27. 2010....
HadA is an atypical new multifunctional trimeric coiled-coil adhesin of Haemophilus influenzae biogroup aegyptius, which promotes entry into host cellsDavide Serruto
Research Center, Novartis Vaccines and Diagnostics, Siena, Italy
Cell Microbiol 11:1044-63. 2009..These data give new insights on the structure-function relationship of oligomeric coiled-coil adhesins and suggest a potential role of this protein in the pathogenesis of BPF...
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansDavide Serruto
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 107:3770-5. 2010..We conclude that GNA2132 is an important protective antigen of N. meningitidis and we propose to rename it, Neisserial Heparin Binding Antigen (NHBA)...
Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombinationSonia Budroni
Research Center, Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 108:4494-9. 2011....
A universal vaccine for serogroup B meningococcusMarzia M Giuliani
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Proc Natl Acad Sci U S A 103:10834-9. 2006..The strain coverage could be increased to 90% and above by the addition of CpG oligonucleotides or by using MF59 as adjuvant. The vaccine has the potential to conquer one of the most devastating diseases of childhood...
Rational design of a meningococcal antigen inducing broad protective immunityMaria Scarselli
Novartis Vaccines and Diagnostics s r l, Via Fiorentina 1, 53100 Siena, Italy
Sci Transl Med 3:91ra62. 2011..We demonstrate that the structure-based design of multiple immunodominant antigenic surfaces on a single protein scaffold is possible and represents an effective way to create broadly protective vaccines...
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesCarole Harfouche
Research Center, Novartis Vaccines and Diagnostics s r l, Siena, Italy
Infect Immun 80:451-60. 2012..These results suggest that a vaccine composed of RrgB321 has the potential to cover 30% or more of all pneumococcal strains and support the inclusion of this fusion protein in a multicomponent vaccine against S. pneumoniae...
Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally relatedMonica Moschioni
Novartis Vaccines, Siena, Italy
J Infect Dis 197:888-96. 2008..Limited data are available on the prevalence of the rlrA operon in pneumococci; therefore, we investigated its distribution and its antigenic variation among disease-causing strains...
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcusMarzia M Giuliani
Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena 53100, Italy
Vaccine 28:5023-30. 2010....
Streptococcus pneumoniae pilus subunits protect mice against lethal challengeClaudia Gianfaldoni
Novartis Vaccines and Diagnostics s r l, Research Center, Via Fiorentina 1, I 53100 Siena, Italy
Infect Immun 75:1059-62. 2007..Both active and passive immunization with recombinant pilus subunits afforded protection against lethal challenge with the S. pneumoniae serotype 4 strain TIGR4...
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1Brunella Brunelli
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 29:1072-81. 2011....
Structural insight into the mechanism of DNA-binding attenuation of the Neisserial adhesin repressor NadR by the small natural ligand 4-hydroxyphenylacetic acidSébastien Brier
Research Center, Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100, Siena, Italy
Biochemistry 51:6738-52. 2012..Altogether our data suggest that the mechanism of regulation of NadR by 4-HPA mainly involves the stabilization of the dimer in a configuration incompatible with DNA binding...
In vitro analysis of protein-operator interactions of the NikR and fur metal-responsive regulators of coregulated genes in Helicobacter pyloriIsabel Delany
Molecular Immunology Unit, Chiron Vaccines, Siena, Italy
J Bacteriol 187:7703-15. 2005..Finally, the importance of an interconnection between metal-responsive gene networks for homeostasis is discussed...
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodiesKate L Seib
Molecular Genetics Unit, Novartis Vaccines, Via Fiorentina, 1, 53100 Siena, Italy
Infect Immun 79:970-81. 2011..Furthermore, cross-reactive bactericidal activity was seen within each variant group, although the degree of activity varied, suggesting that amino acid differences within each variant group influence the bactericidal antibody response...
Molecular architecture of Streptococcus pneumoniae TIGR4 piliMarkus Hilleringmann
Research Center, Novartis Vaccines and Diagnostics s r l, Siena, Italy
EMBO J 28:3921-30. 2009..Our structural analyses provide the first direct experimental evidence that the native S. pneumoniae pilus shaft is composed exclusively of covalently linked monomeric RrgB subunits oriented head-to-tail...
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in miceAndreas Wack
Novartis Vaccines, Via Fiorentina 1, Siena, Italy
Vaccine 26:552-61. 2008..These observations have significant implications for the development of new and improved flu vaccines against pandemic and inter-pandemic influenza virus strains...
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesJohn Donnelly
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 107:19490-5. 2010..This assay allows typing of large panels of strains and prediction of coverage of protein-based meningococcal vaccines. Similar assays may be used for protein-based vaccines against other bacteria...
Vaccinology in the genome eraC Daniela Rinaudo
Novartis Vaccines, Siena, Italy
J Clin Invest 119:2515-25. 2009..Furthermore, structural vaccinology is emerging as a powerful tool for the rational design or modification of vaccine antigens to improve their immunogenicity and safety...
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcusStefania Bambini
Novartis V and D, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 27:2794-803. 2009..Sequencing each gene in the different strains will be important to evaluate antigen conservation and assortment and to allow a future prediction of potential vaccine coverage...
Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approachMarirosa Mora
Novartis Vaccines, Via Fiorentina, 53100 Siena, Italy
Curr Opin Microbiol 9:532-6. 2006..The practical consequence is that, in many cases, a universal vaccine is possible only by including a combination of antigens and this combination must take into account the pathogen population structure...
NarE: a novel ADP-ribosyltransferase from Neisseria meningitidisVega Masignani
IRIS, Chiron S.r.l, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 50:1055-67. 2003..When present, the gene is 100% conserved in sequence and is inserted upstream of and co-transcribed with the lipoamide dehydrogenase E3 gene. Possible roles in the pathogenesis of N. meningitidis are discussed...
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cellsBarbara Capecchi
Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 55:687-98. 2005..NadA is likely to improve the fitness of N. meningitidis contributing to the increased virulence of strains that belong to the hypervirulent lineages...
Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogensDavide Serruto
IRIS, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
J Biotechnol 113:15-32. 2004..In addition, we describe the potential of these powerful technologies in understanding the pathogenesis of various bacteria...
The factor H binding protein of Neisseria meningitidis interacts with xenosiderophores in vitroDaniele Veggi
Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena, Italy
Biochemistry 51:9384-93. 2012..Our results indicated that the enterobactin binding site was distinct from the site involved in binding to human factor H and stimulates new hypotheses about possible multiple activities of fHbp...
Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survivalHebert Echenique-Rivera
Novartis Vaccines and Diagnostics, Siena, Italy
PLoS Pathog 7:e1002027. 2011..This increased knowledge of how Nm responds to adaptation in blood could also be helpful to develop diagnostic and therapeutic strategies to control the devastating disease cause by this microorganism...
Designing the next generation of vaccines for global public healthFabio Bagnoli
Novartis Vaccines and Diagnostics, Siena, Italy
OMICS 15:545-66. 2011..Finally, we present a discussion to situate omics-guided rational vaccine design in the broader context of global public health and how it can benefit citizens in both developed and developing countries...
The impact of genomics on vaccine designMaria Scarselli
Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Trends Biotechnol 23:84-91. 2005..In this review, we describe how genomic approaches can be used to identify novel vaccine candidates or create safer live-attenuated vaccines...
Effect of Neisseria meningitidis fur mutations on global control of gene transcriptionIsabel Delany
Molecular Immunology Unit, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
J Bacteriol 188:2483-92. 2006..We began to dissect the regulatory networks of Fur and the heat shock (stress) response in N. meningitidis, and the observed interlink between the two circuits is discussed...
N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccinesKarin Baraldo
Research Center, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Infect Immun 72:4884-7. 2004..N19-based conjugates are superior to CRM-based conjugates to induce protective immune responses to MenC conjugates...
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squaleneGiuseppe Del Giudice
Research Center, Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Clin Vaccine Immunol 13:1010-3. 2006..In conclusion, antisqualene antibodies are not increased by immunization with vaccines with the MF59 adjuvant. These data extend the safety profile of the MF59 emulsion adjuvant...
NadA diversity and carriage in Neisseria meningitidisMaurizio Comanducci
IRIS, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Infect Immun 72:4217-23. 2004..The presence of NadA can therefore be used as a tool to study the dynamics of meningococcal infections and understand why this bacterium, which is mostly a commensal, can become a severe pathogen...
Seasonal influenza vaccine provides priming for A/H1N1 immunizationGiuseppe Del Giudice
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Sci Transl Med 1:12re1. 2009..The vaccine given without adjuvant significantly reduced viral load in the lungs but did not protect from infection. Only the vaccine with adjuvant completely prevented both pulmonary and nasal infection...
The genome revolution in vaccine researchBarbara Capecchi
IRIS, Chiron S.r.l, Via Fiorentina 1, 53100 Siena, Italy
Curr Issues Mol Biol 6:17-27. 2004..The concept of "Reverse Vaccinology" can be easily applied to all the pathogens for which vaccines are not yet available and can be extended to parasites and viruses...
Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophagesRosanna Leuzzi
IRIS, Chiron S.r.l, Via Fiorentina, 1, 53100 Siena, Italy
Mol Microbiol 58:669-81. 2005..We show that Ng-MIP promotes the intracellular survival of N. gonorrhoeae in macrophages, highlighting a possible role of this protein in promoting the persistence of gonococcal infection...
Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidisIsabel Delany
Biochemistry and Molecular Biology Unit, IRIS, Chiron S.r.l, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 52:1081-90. 2004..Deletion of the upstream operator in the norB promoter abolished activation of transcription in vivo in response to iron and in vitro in response to Fur. The role of such a dual mechanism of Fur regulation during infection is discussed...
Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infectionsAnnalisa Nuccitelli
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 108:10278-83. 2011..In addition, this work describes a template procedure that can be followed to develop vaccines against other bacterial pathogens...
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodiesElisa Faenzi
Research Development, Novartis Vaccines and Diagnostics Srl, Siena, Italy
Vaccine 30:4086-94. 2012..These data shed light on the different components of the immune response to the 2009 H1N1 pandemic influenza vaccination and may have implications in the design of vaccination strategies against future influenza pandemics...
Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasionPaolo Montanari
Research Center, Novartis Vaccines and Diagnostics, Siena, Italy
Cell Microbiol 14:368-85. 2012..Altogether our results show that variation of host Hsp90 expression or activity interferes with adhesive and invasive events driven by NadA...
Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coliDanilo Gomes Moriel
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 107:9072-7. 2010..The gene encoding the most protective antigen was detected in most of the E. coli isolates, highly conserved in sequence and found to be exported by a type II secretion system which seems to be nonfunctional in nonpathogenic strains...
Long-term solutions for the problem of vaccine shortagesMaria Lattanzi
Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Expert Opin Biol Ther 4:989-92. 2004..This article will provide examples of how public-private partnerships both in developed and developing countries have been established to handle specific problems concerning vaccination...
Dual control of Helicobacter pylori heat shock gene transcription by HspR and HrcAGunther Spohn
Biochemistry and Molecular Biology Unit, IRIS, 53100 Siena, Italy
J Bacteriol 186:2956-65. 2004..The implications of these findings for the elucidation of the networks regulating heat shock gene expression in H. pylori are discussed...
The use of genomics in microbial vaccine developmentStefania Bambini
Novartis Vaccines, Siena, Italy
Drug Discov Today 14:252-60. 2009..Overall, the conventional empiric approach to vaccine development is being replaced by vaccine design. The recent development of synthetic genomics may provide a further opportunity to design vaccines...
Identification of an iron-sulfur cluster that modulates the enzymatic activity in NarE, a Neisseria meningitidis ADP-ribosyltransferaseMariangela Del Vecchio
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
J Biol Chem 284:33040-7. 2009..This is the first observation suggesting that a member of the ADP-ribosyltransferase family contains an Fe-S cluster implicated in catalysis. This observation may unravel novel functions exerted by this class of enzymes...
Reverse vaccinology and genomicsRino Rappuoli
IRIS, Chiron Vaccines, 53100 Siena, Italy
Science 302:602. 2003..The genomic revolution has had a dramatic effect on our ability to find new vaccine targets and develop effective vaccines...
Microbiology in the post-genomic eraDuccio Medini
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Nat Rev Microbiol 6:419-30. 2008....
The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterialsAlessandro Muzzi
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Drug Discov Today 12:429-39. 2007....
Genome-based vaccine development: a short cut for the futureDanilo Gomes Moriel
Novartis Vaccines, Siena, Italy
Hum Vaccin 4:184-8. 2008..A lot of work must be done, but deciphering the information provided by genome sequences and using it to better understand the host-pathogen interactions has proved to be the key for protection...
Vaccines in the era of genomics: the pneumococcal challengeMichèle Anne Barocchi
Novartis Vaccines, Via Fiorentina, 53100 Siena, Italy
Vaccine 25:2963-73. 2007..Ultimately, the identification of immunogenic surface antigens and assessment of their efficacy will be imperative in the development of a vaccine with the ability to protect against invasive disease independent of serotype...
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodiesMarzia Monica Giuliani
IRIS, Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Infect Immun 73:1151-60. 2005..Arginine in position 204 was identified as important for binding of the monoclonal antibody. The identification of the region containing bactericidal epitopes is an important step in the design of new vaccines against meningococci...
CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcriptionRaffaele Ieva
Biochemistry and Molecular Biology Unit, Chiron Vaccines, 53100 Siena, Italy
J Bacteriol 187:3421-30. 2005..The role of CrgA in the regulation of gene expression during the infectious cycle of N. meningitidis is discussed...
An anti-repression Fur operator upstream of the promoter is required for iron-mediated transcriptional autoregulation in Helicobacter pyloriIsabel Delany
Biochemistry and Molecular Biology Unit, IRIS, Chiron S rl, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 50:1329-38. 2003..We propose that its role is ensuring that Fur expression is not repressed below a minimum threshold level. Our data supports a novel promoter architecture and mechanism of regulation by Fur...
Generating memory with vaccinationFlora Castellino
Research Center, Novartis Vaccines, Siena, Italy
Eur J Immunol 39:2100-5. 2009..We will also discuss how extending clinical investigation to events occurring early after vaccination can help identify early predictive markers of protective memory and thus contribute to faster development of better and safer vaccines...
Factor H-binding protein, a unique meningococcal vaccine antigenMariagrazia Pizza
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 26:I46-8. 2008..fHbp is important for survival in human blood, human sera, and in presence of antimicrobial peptides, independently of its expression level. All these properties make fHbp a unique vaccine antigen...
The key role of genomics in modern vaccine and drug design for emerging infectious diseasesKate L Seib
Novartis Vaccines and Diagnostics, Siena, Italy
PLoS Genet 5:e1000612. 2009..This ever-growing body of genomic data and new genome-based approaches will play a critical role in the future to enable timely development of vaccines and therapeutics to control emerging infectious diseases...
Pili in gram-positive pathogensJohn L Telford
Novartis Vaccines and Diagnostics Srl, Via Fiorentina 1, 53100 Siena, Italy
Nat Rev Microbiol 4:509-19. 2006....
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccinesBarbara C Baudner
IRIS Research Center, Chiron SpA, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 21:3837-44. 2003..These results demonstrate that the concomitant use of chitosan microparticles and the LTK63 mutant significantly enhances the immunogenicity and the protective efficacy of vaccines given intranasally...
Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiencyMarta Marchetti
Immunobiological Research Institute of Siena IRIS Chiron Spa, Via Fiorentina 1, 53100 Siena, Italy
Microbiology 148:1447-56. 2002..These results suggest that the structure of the H. pylori secretion apparatus itself is involved in this process...
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccineGiuseppe Del Giudice
Chiron Vaccines, Research Center and Clinical Research, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 24:3063-5. 2006..We conclude that MF59-adjuvanted vaccines confer protection also against influenza virus strains which are not fully matched with those included in the vaccine...
MF59 adjuvant: the best insurance against influenza strain diversityDerek T O'Hagan
Novartis Vaccines and Diagnostics, Cambridge, MA, USA
Expert Rev Vaccines 10:447-62. 2011....
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Anja Seubert
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 108:11169-74. 2011..Because MF59 did not activate any of the Toll-like receptors in vitro, we propose that MF59 requires MyD88 for a Toll-like receptor-independent signaling pathway...
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all agesMichael Broker
Novartis Vaccines and Diagnostics GmbH and Co KG, 35041 Marburg, Germany
Vaccine 27:5574-80. 2009....
Influenza vaccine immunologyPhilip R Dormitzer
Novartis Vaccines and Diagnostics, Siena, Italy
Immunol Rev 239:167-77. 2011..The MF59 adjuvant broadens the distribution of B-cell epitopes recognized on HA and NA following immunization...
Development of vaccines against Helicobacter pyloriGiuseppe Del Giudice
Research Center, Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Expert Rev Vaccines 8:1037-49. 2009..These data show that vaccination against this pathogen is feasible. More research is required to understand the immunological mechanisms underlying immune-mediate protection...
Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitroGeorge F Santos
Novartis Vaccines, 350 Mass Ave, Cambridge, MA 02139, USA
Clin Vaccine Immunol 16:1693-5. 2009..Serum bactericidal antibody titers against selected bacteria were within assay variability through a selection event frequency of 1 in 10(-5). No change in antigen expression was observed by Western blotting...
Towards a vaccine against Escherichia coli-associated urinary tract infectionsLaura Serino
Novartis Vaccines and Diagnostics, Research Centre, Via Fiorentina 1, 53100 Siena, Italy
Future Microbiol 5:351-4. 2010....
Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applicationsMichael Broker
Novartis Vaccines and Diagnostics GmbH, Marburg, Germany
Biologicals 39:195-204. 2011..Additional clinical applications of CRM(197), as in chemotherapy, also exist...
A novel epigenetic regulator associated with the hypervirulent Neisseria meningitidis clonal complex 41/44Kate L Seib
Microbial Molecular Biology, Novartis Vaccines, Via Fiorentina, 1, 53100 Siena, Italy
FASEB J 25:3622-33. 2011..The modulation of gene expression via the ModD phase-variable regulon (phasevarion), and its significant association with the cc41/44, suggest a role in the fitness and/or pathogenesis of strains belonging to the cc41/44...
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarraysRenata Grifantini
Chiron SpA, Via Fiorentina 1, 53100 Siena, Italy
Nat Biotechnol 20:914-21. 2002....
Alum adjuvanticity: unraveling a century old mysteryEnnio De Gregorio
Department of Immunology, Novartis Vaccines and Diagnostics, Siena, Italy
Eur J Immunol 38:2068-71. 2008..Surprisingly, these three studies reported conflicting results on the requirement of the Nlrp3 inflammasome complex for alum adjuvant effects in vivo. This commentary attempts to resolve some of these discrepancies...
Structure-based antigen design: a strategy for next generation vaccinesPhilip R Dormitzer
Novartis Vaccines and Diagnostics, Inc, 350 Massachusetts Ave, Cambridge, MA 02139, USA
Trends Biotechnol 26:659-67. 2008..Understanding the structural basis for immunogenicity and immunodominance will allow us to improve vaccine efficacy and broaden the range of vaccine-preventable diseases...
Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious processJ Daniel Dubreuil
IRIS Research Center, Chiron SpA, 53100 Siena, Italy
Microbiol Mol Biol Rev 66:617-29, table of contents. 2002..A more thorough understanding of the kinetics of these receptin interactions could provide a new approach to preventing deeper tissue invasion in H. pylori infections and could represent an alternative to antibiotic treatment...
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complementSamuele Peppoloni
IRIS Research Center, Chiron SpA, Via Fiorentina 1, I 53100 Siena, Italy
Eur J Immunol 32:2721-5. 2002..Cytochalasin D significantly impaired this antibacterial activity, suggesting that phagocytosis plays a major role in the antibody-mediated H. pylori killing...
Helicobacter pylori: after the genomes, back to biologyAntonello Covacci
IRIS, Chiron Vaccines Srl, Via Fiorentina 1, 53100 Siena, Italy
J Exp Med 197:807-11. 2003
GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulenceJeannette Adu-Bobie
IRIS, Chiron Vaccines, 53100 Siena, Italy
Infect Immun 72:1914-9. 2004..We conclude that GNA33 is a highly conserved lipoprotein which plays an important role in peptidoglycan metabolism, cell separation, membrane architecture, and virulence...
c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifsMarkus Stein
IRIS Chiron S.p.A, Via Fiorentina 1, 53100 Siena, Italy
Mol Microbiol 43:971-80. 2002..Thus, CagA translocation followed by tyrosine phosphorylation at the EPIYA motifs promotes a growth factor-like response with intense cytoskeletal rearrangements, cell elongation effects and increased cellular motility...
Vaccine adjuvants: the dream becomes realAldo Tagliabue
ALTA R and D in Biotechnology, Siena, Italy
Hum Vaccin 4:347-9. 2008..It is absorbed on aluminum hydroxide or aluminum phosphate. Thus, new molecules are available to improve the immune response to vaccines also in humans: this is the beginning of a new era in vaccinology...
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza virusesIsabella Alberini
Novartis Vaccines, Siena, Italy
Vaccine 27:5998-6003. 2009..Overall, the PPN assay represents a valid alternative to conventional serological methods for the evaluation of H5N1 vaccine immunogenicity...
